A major advance in cancer study is emerging with the use of mini-antibodies to re-engage dysfunctional p53. This essential malignant protector protein is frequently inactivated in several kinds of cancer, causing https://cyberbookmarking.com/story21858114/vhh-fragments-revive-p53-new-new-hope-for-malignant-therapy